New urine test could help track kidney health
NCT ID NCT07348484
Summary
This study aims to learn more about chronic kidney disease by observing patients in real-world settings. It will follow 300 adults with moderate kidney disease to see if a common class of drugs (SGLT2 inhibitors like empagliflozin) helps slow the decline of kidney function. The study will also test a new panel of urine biomarkers to see if they can help diagnose and monitor the disease earlier.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Universitario de Salamanca
Salamanca, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.